EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thiosemicarbazone-Based Compounds: A Promising Scaffold for Developing Antibacterial, Antioxidant, and Anticancer Therapeutics

Agnieszka Czylkowska iD, Monika Pitucha iD, Anita Raducka, Ewelina Fornal iD, Edyta Kordialik-Bogacka iD, Sylwia Ścieszka iD, Marek Smoluch iD, Franciszek Burdan, Mateusz Jędrzejec, Paweł Szymański iD

Molecules · 31.12.2024 · 30 (1) · 129

DOI: 10.3390/molecules30010129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 31.12.2024. Verfasst von Agnieszka Czylkowska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland. Hauptthemen laut MEDLINE: Thiosemicarbazones, Antioxidants, Anti-Bacterial Agents, Antineoplastic Agents. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper presents the synthesis and characterization of new thiosemicarbazone derivatives with potential applications as antibacterial, antioxidant and anticancer agents. Six thiosemicarbazone derivatives (L–L5) were synthesized by reacting an appropriate thiosemicarbazide derivative with 2-pyridinecarboxaldehyde. The structures of the obtained compounds were confirmed using mass spectrometry, infrared spectroscopy, and NMR spectroscopy. Antibacterial activity was evaluated by using the microdilution method, determining the minimum inhibitory concentration (MIC) against a panel of Gram-positive and Gram-negative bacteria. Compound L1 showed the most potent antibacterial activity, especially against Bacillus cereus (MIC 10 mg/L). Molecular docking to topoisomerase II and transcriptional regulator PrfA suggests that the studied compounds can effectively bind to molecular targets recognized in anticancer and antibacterial therapies. An assessment of physicochemical properties (ADME) indicates favorable parameters of the compounds as potential drugs. Compounds L and L2 showed the highest antioxidant activity, surpassing the activity of the Trolox standard. Cytotoxicity against A549 lung cancer cells was evaluated by the MTT assay. Compound L4 exhibited the strongest inhibitory effect on cancer cell survival. The obtained results indicate that the synthesized thiosemicarbazide derivatives, especially L1, L2, and L4, are promising compounds with potential applications as antibacterial and anticancer drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiosemicarbazonesAntioxidantsAnti-Bacterial AgentsAntineoplastic AgentsHumansMicrobial Sensitivity TestsMolecular Docking SimulationCell SurvivalStructure-Activity RelationshipMolecular StructureA549 Cells

Stichwörter der Autor:innen

antibacterial activityanticancer therapeuticsantioxidantthiosemicarbazone

Substanzen

ThiosemicarbazonesAntioxidantsAnti-Bacterial AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Lodz, Poland.
  • Independent Radiopharmacy Unit, Faculty of Pharmacy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.
  • Institute of Fermentation Technology and Microbiology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Wólczańska 171/173, 90-924 Lodz, Poland.
  • Faculty of Materials Science and Ceramics, AGH University, Mickiewicza 30, 30-059 Krakow, Poland.
  • Human Anatomy Department, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland.
  • Department of Pharmaceutical Chemistry, Drug Analyses and Radiopharmacy, Faculty of Pharmacy, Medical University of Lodz, 90-151 Lodz, Poland.

ORCID-Profile: Agnieszka Czylkowska, Monika Pitucha, Ewelina Fornal, Edyta Kordialik-Bogacka, Sylwia Ścieszka, Marek Smoluch, Paweł Szymański

Zitieren

APA

Czylkowska, A., Pitucha, M., Raducka, A., Fornal, E., Kordialik-Bogacka, E., Ścieszka, S., Smoluch, M., Burdan, F., Jędrzejec, M., & Szymański, P. (2024). Thiosemicarbazone-Based Compounds: A Promising Scaffold for Developing Antibacterial, Antioxidant, and Anticancer Therapeutics. Molecules, 30(1), 129. https://doi.org/10.3390/molecules30010129

Vancouver

Czylkowska A, Pitucha M, Raducka A, Fornal E, Kordialik-Bogacka E, Ścieszka S, et al. Thiosemicarbazone-Based Compounds: A Promising Scaffold for Developing Antibacterial, Antioxidant, and Anticancer Therapeutics. Molecules. 2024;30(1):129. doi:10.3390/molecules30010129

BibTeX
@article{Czylkowska2024,
  author = {Czylkowska, Agnieszka and Pitucha, Monika and Raducka, Anita and Fornal, Ewelina and Kordialik-Bogacka, Edyta and Ścieszka, Sylwia and Smoluch, Marek and Burdan, Franciszek and Jędrzejec, Mateusz and Szymański, Paweł},
  title = {Thiosemicarbazone-Based Compounds: A Promising Scaffold for Developing Antibacterial, Antioxidant, and Anticancer Therapeutics},
  journal = {Molecules},
  year = {2024},
  volume = {30},
  number = {1},
  pages = {129},
  doi = {10.3390/molecules30010129}
}
Kostenlos starten →